Company Profile
Lasa Supergenerics provides the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol
API products, as well as animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. Additionally, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.